Cerus Corporation (CERS): Price and Financial Metrics
CERS Price/Volume Stats
| Current price | $1.51 | 52-week high | $2.54 |
| Prev. close | $1.38 | 52-week low | $1.12 |
| Day low | $1.39 | Volume | 4,340,800 |
| Day high | $1.58 | Avg. volume | 1,428,348 |
| 50-day MA | $1.33 | Dividend yield | N/A |
| 200-day MA | $1.66 | Market Cap | 288.65M |
CERS Stock Price Chart Interactive Chart >
Cerus Corporation (CERS) Company Bio
Cerus Corporation operates as a biomedical products company which focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company was founded in 1991 and is based in Concord, California.
CERS Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CERS Price Returns
| 1-mo | 11.03% |
| 3-mo | 0.00% |
| 6-mo | -15.64% |
| 1-year | -15.17% |
| 3-year | -71.51% |
| 5-year | -74.14% |
| YTD | -1.95% |
| 2024 | -28.70% |
| 2023 | -40.82% |
| 2022 | -46.40% |
| 2021 | -1.59% |
| 2020 | 63.98% |